These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 3278232
1. Methotrexate in the treatment of corticosteroid-dependent asthma. A double-blind crossover study. Mullarkey MF, Blumenstein BA, Andrade WP, Bailey GA, Olason I, Wetzel CE. N Engl J Med; 1988 Mar 10; 318(10):603-7. PubMed ID: 3278232 [Abstract] [Full Text] [Related]
2. Methotrexate in the management of severe steroid dependent asthma. Taylor DR, Flannery EM, Herbison GP. N Z Med J; 1993 Sep 22; 106(964):409-11. PubMed ID: 8377957 [Abstract] [Full Text] [Related]
3. [Methotrexate in the treatment of asthma. Open trial in 10 corticoid-dependent patients with severe asthma]. Becquart LA, Wallaert B, Lassalle P, Guéné-Ribassin C, Tonnel AB. Rev Mal Respir; 1994 Sep 22; 11(6):565-71. PubMed ID: 7831506 [Abstract] [Full Text] [Related]
5. Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma. Karpel JP, Nayak A, Lumry W, Craig TJ, Kerwin E, Fish JE, Lutsky B. Respir Med; 2007 Mar 22; 101(3):628-37. PubMed ID: 16875813 [Abstract] [Full Text] [Related]
6. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, Hargreave FE, O'Byrne PM. N Engl J Med; 2009 Mar 05; 360(10):985-93. PubMed ID: 19264687 [Abstract] [Full Text] [Related]
7. Methotrexate for the treatment of chronic corticosteroid-dependent asthma. Reid DJ, Segars LW. Clin Pharm; 1993 Oct 05; 12(10):762-7. PubMed ID: 8258256 [Abstract] [Full Text] [Related]
8. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. Haahtela T, Järvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Nikander K, Persson T, Selroos O, Sovijärvi A. N Engl J Med; 1994 Sep 15; 331(11):700-5. PubMed ID: 8058076 [Abstract] [Full Text] [Related]
9. Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma. Hothersall EJ, Chaudhuri R, McSharry C, Donnelly I, Lafferty J, McMahon AD, Weir CJ, Meiklejohn J, Sattar N, McInnes I, Wood S, Thomson NC. Thorax; 2008 Dec 15; 63(12):1070-5. PubMed ID: 18757458 [Abstract] [Full Text] [Related]
10. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group. Giannini EH, Brewer EJ, Kuzmina N, Shaikov A, Maximov A, Vorontsov I, Fink CW, Newman AJ, Cassidy JT, Zemel LS. N Engl J Med; 1992 Apr 16; 326(16):1043-9. PubMed ID: 1549149 [Abstract] [Full Text] [Related]
12. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus. Carneiro JR, Sato EI. J Rheumatol; 1999 Jun 16; 26(6):1275-9. PubMed ID: 10381042 [Abstract] [Full Text] [Related]
13. Comparison of oral pulse methotrexate with placebo in the treatment of severe glucocorticosteroid-dependent asthma. Stewart GE, Diaz JD, Lockey RF, Seleznick MJ, Trudeau WL, Ledford DK. J Allergy Clin Immunol; 1994 Sep 16; 94(3 Pt 1):482-9. PubMed ID: 8083453 [Abstract] [Full Text] [Related]
14. High-dose intramuscular triamcinolone in severe, chronic, life-threatening asthma. Ogirala RG, Aldrich TK, Prezant DJ, Sinnett MJ, Enden JB, Williams MH. N Engl J Med; 1991 Feb 28; 324(9):585-9. PubMed ID: 2021388 [Abstract] [Full Text] [Related]
15. Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma. Fish JE, Karpel JP, Craig TJ, Bensch GW, Noonan M, Webb DR, Silverman B, Schenkel EJ, Rooklin AR, Ramsdell JW, Nathan R, Leflein JG, Grossman J, Graft DF, Gower RG, Garay SM, Frigas E, Degraff AC, Bronsky EA, Bernstein DI, Berger W, Shneyer L, Nolop KB, Harrison JE. J Allergy Clin Immunol; 2000 Nov 28; 106(5):852-60. PubMed ID: 11080706 [Abstract] [Full Text] [Related]
16. A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma. Wasserman SI, Gross GN, Schoenwetter WF, Munk ZM, Kral KM, Schaberg A, Kellerman DJ. J Asthma; 1996 Nov 28; 33(4):265-74. PubMed ID: 8707781 [Abstract] [Full Text] [Related]
17. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial). Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening A, Haahtela T, Holgate ST, Picado C, Leff JA. Respir Med; 2000 Jun 28; 94(6):612-21. PubMed ID: 10921768 [Abstract] [Full Text] [Related]
18. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler. Murphy K, Noonan M, Silkoff PE, Uryniak T. Clin Ther; 2007 Jun 28; 29(6):1013-26. PubMed ID: 17692718 [Abstract] [Full Text] [Related]
19. The role of methotrexate in the management of steroid-dependent asthma. Coffey MJ, Sanders G, Eschenbacher WL, Tsien A, Ramesh S, Weber RW, Toews GB, McCune WJ. Chest; 1994 Jan 28; 105(1):117-21. PubMed ID: 7903921 [Abstract] [Full Text] [Related]
20. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Humbert M, Beasley R, Ayres J, Slavin R, Hébert J, Bousquet J, Beeh KM, Ramos S, Canonica GW, Hedgecock S, Fox H, Blogg M, Surrey K. Allergy; 2005 Mar 28; 60(3):309-16. PubMed ID: 15679715 [Abstract] [Full Text] [Related] Page: [Next] [New Search]